Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in

Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Current Issue

01 Nov 2025 (Vol. 92 Issue 11) Table of Contents
Cleveland Clinic Journal of Medicine: 92 (11)

Issue highlights

  • Lipoprotein(a) in clinical practice: What clinicians need to know
  • Should we continue guideline-directed medical therapy in patients with heart failure with improved ejection fraction?
  • Managing obesity in older adults
  • Thyroid eye disease: What’s the latest?

Summaries from Kidney Week 2025

Summaries from ACR Convergence 2025

Featured Articles

  • Multiple scabietic nodules on the scrotum in a patient living with HIV infection
    November 03, 2025
  • Teprotumumab for thyroid eye disease: A reality check
    November 03, 2025
  • Lipoprotein(a) in clinical practice: What clinicians need to know
    November 03, 2025
  • Nearly a century of using glucocorticoids in patients with active infection
    October 01, 2025
  • MDA5 dermatomyositis: Unveiling a potentially life-threatening disease
    October 01, 2025
  • What is the role of cystatin C in estimating glomerular filtration rate and guiding medication...
    September 02, 2025
  • An overview of over-the-counter contraceptives: Spotlight on daily oral norgestrel
    September 02, 2025
  • Acute respiratory distress syndrome: Why a definition matters
    September 02, 2025
  • Does my patient need testing for PFAS ‘forever chemicals’?
    August 01, 2025
  • Newer diabetes drugs: Surprising shared benefits and unique side effects
    August 01, 2025
  • The overlooked and undertreated perils of premature ovarian insufficiency
    August 01, 2025
  • Insights from the LAAOS III trial of left atrial appendage occlusion to prevent stroke in atrial...
    July 01, 2025
  • Breast cancer risk and screening for transgender and gender-diverse individuals
    July 01, 2025
  • Immunotherapy meets William Shakespeare
    July 01, 2025

Latest Articles

  • You have access
    Rethinking recovery in heart failure: Beyond improvement in left ventricular ejection fraction
    Nandan Kodur, BS and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 673-675; DOI: https://doi.org/10.3949/ccjm.92a.25078

    The authors discuss 3 unresolved questions about de-escalating and escalating guideline-directed medical therapy in patients with improved ejection fraction.

  • You have access
    Teprotumumab for thyroid eye disease: A reality check
    Julian Perry, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 702-703; DOI: https://doi.org/10.3949/ccjm.92a.25066

    Initial enthusiasm for teprotumumab as therapy for thyroid eye disease has been tempered by longitudinal data suggesting that it often does not alter the natural disease course.

  • You have access
    Managing obesity in older adults
    CME article
    Shyam Sundaresh, MD, Sara Saliba, MD, RD, Farah Ziyadeh, MD, Yael Mauer, MD, MPH and Willy Marcos Valencia, MD, MSc
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 686-692; DOI: https://doi.org/10.3949/ccjm.92a.24094

    The goals of treating obesity in older adults are to ease its complications and improve functional status and quality of life, with or without weight loss.

  • You have access
    Chronic ocular pain
    Radhika S. Amin, Eliot N. Haddad and Rony R. Sayegh, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 652; DOI: https://doi.org/10.3949/ccjm.92c.11003
  • You have access
    Failure to thrive in hospitalized older adults: More than a ‘social admission’
    Shoshana Streiter, MD and Samir Tulebaev, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 662-666; DOI: https://doi.org/10.3949/ccjm.92a.25033

    Failure to thrive documented as an admitting diagnosis presents an opportunity to identify, articulate, and begin to ameliorate the true underlying causes of the patient’s health deficits.

  • You have access
    What is the optimal time for bone density screening in patients with premature ovarian insufficiency?
    Dewonna Ferguson, MD, MSCP, Suneela Vegunta, MD, MSCP and Sara Shihab, MD, MSCP
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 676-678; DOI: https://doi.org/10.3949/ccjm.92a.24116

    Dual-energy x-ray absorptiometry should be performed at diagnosis, with the timing of repeat scans predicated on the patient’s clinical risk factors for fracture.

  • You have access
    In Reply: Managing noninsulin glucose-lowering medications before surgery
    Oscar L. Morey-Vargas, MD, Mona Gossmann, MD, Jeffrey M. Ketz, PharmD and Basem B. Abdelmalak, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 651-652; DOI: https://doi.org/10.3949/ccjm.92c.11002
  • Lipoprotein(a) in clinical practice: What clinicians need to know
    You have access
    Lipoprotein(a) in clinical practice: What clinicians need to know
    Astefanos Al-Dalakta, MD, Leslie S. Cho, MD and Ashish Sarraju, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 679-685; DOI: https://doi.org/10.3949/ccjm.92a.25020

    Elevated lipoprotein(a) by itself is not an indication for statin therapy, but its presence supports earlier or more aggressive preventive therapy.

  • You have access
    Thyroid eye disease: What’s the latest?
    CME article
    Ashley B. Vincent, DO, Alexander R. Engelmann, MD, Catherine J. Hwang, MD and Christian Nasr, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 693-701; DOI: https://doi.org/10.3949/ccjm.92a.25043

    A better understanding of the pathophysiology of this autoimmune disorder has led to innovative insights into its treatment, but long-term management remains a challenge.

  • You have access
    Should we continue guideline-directed medical therapy in patients with heart failure with improved ejection fraction?
    Nicole Ann Tesoro, MD and Sumanth Kumar Bandaru, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 667-670; DOI: https://doi.org/10.3949/ccjm.92a.24111

    Therapy should be continued even if left ventricular ejection fraction improves, as normalization or improvement does not guarantee a permanent recovery.

View more latest articles
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Rethinking recovery in heart failure: Beyond improvement in left ventricular ejection fraction
Failure to thrive in hospitalized older adults: More than a ‘social admission’
What is the optimal time for bone density screening in patients with premature ovarian insufficiency?
No surprise, all inflammation is not created equal as it relates to cardiovascular disease
Benign migratory glossitis
Flexibility is warranted in applying prescribing guidelines
How can I help my pregnant patients quit using tobacco?
Half-moccasin distribution of acute tinea pedis
Cerebrovascular complications in infective endocarditis: Challenges and considerations in management
Evolving paradigms in hypertension management: Fixed-dose single-pill combinations and future therapies
Refractory granuloma annulare
How should I manage my patient with cancer who is experiencing diarrhea while on immunotherapy?
Odontogenic cutaneous fistula

Cleveland Clinic Journal of Medicine, published by Cleveland Clinic, provides busy clinicians with practical information to promote better patient care.

Back to top

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire